Context Therapeutics Inc (CNTX)
1.38
-0.12
(-8.00%)
USD |
NASDAQ |
Nov 22, 10:08
Context Therapeutics Shareholders Equity (Quarterly): 83.86M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 83.86M |
| June 30, 2024 | 101.10M |
| March 31, 2024 | 8.443M |
| December 31, 2023 | 11.87M |
| September 30, 2023 | 18.38M |
| June 30, 2023 | 24.00M |
| March 31, 2023 | 28.73M |
| December 31, 2022 | 34.76M |
| Date | Value |
|---|---|
| September 30, 2022 | 38.07M |
| June 30, 2022 | 41.65M |
| March 31, 2022 | 45.39M |
| December 31, 2021 | 48.27M |
| September 30, 2021 | -23.21M |
| June 30, 2021 | -22.30M |
| March 31, 2021 | -17.48M |
| December 31, 2020 | -16.92M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-23.21M
Minimum
Sep 2021
101.10M
Maximum
Jun 2024
25.29M
Average
26.37M
Median
Shareholders Equity (Quarterly) Benchmarks
| Collegium Pharmaceutical Inc | 234.28M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 86.33M |
| Total Liabilities (Quarterly) | 2.472M |